Operating Income (Loss)
Breakdown
Segments
Generics and OtherView metric
Rare Disease and BrandsView metric
| Segment | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|
| Generics and Other | $48.54M | $38.18M | $35.08M | $33.19M | $40.32M |
| Rare Disease and Brands | $21.13M | $29.46M | $41.66M | $48.99M | $36.25M |
| Total | $26.19M | $13.89M | $36.24M | $34.77M | $38.89M |